Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*

Vincent, Jean-Louis; Privalle, Christopher; Singer, Mervyn; Lorente Balanza, José Ángel; Boehm, Erwin; Meier-Hellmann, Andreas; Darius, Harald; Ferrer, Ricard; Sirvent, Josep Maria; Marx, Gernot; DeAngelo, Joseph

doi:10.1097/CCM.0000000000000554

Inicio

Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*

Vincent, Jean-Louis; Privalle, Christopher; Singer, Mervyn; Lorente Balanza, José Ángel; Boehm, Erwin; Meier-Hellmann, Andreas; Darius, Harald; Ferrer, Ricard; Sirvent, Josep Maria; Marx, Gernot; DeAngelo, Joseph

Use este identificador para citar o enlazar este ítem: http://hdl.handle.net/11268/4216

Fecha: 2015

Materia UNESCO: Enfermedad cardiovascular

Tipo: article

Exportar a:

Resumen:

The objective of this study is to compare the effectiveness and safety of the hemoglobin-based nitric oxide scavenger, pyridoxalated hemoglobin polyoxyethylene, against placebo in patients with vasopressor-dependent distributive shock.

Mostrar el registro completo del ítem